Gacci M1, Artibani W2, Bassi P3, Bertoni F4, Bracarda S5, Conti G6, Corvò R7, Graziotti P8, Maggi S9, Magrini S M10, Maurizi E R11, Mirone V12, Montironi R13, Muto G14, Noale M9, Pecoraro S15, Porreca A16, Ricardi U17, Tubaro A18, Zagonel V19, Zattoni F20, Crepaldi G9
1. Department of Urology, University of Florence (Italy), 2. Urologic Clinic, Department of Oncological and Surgical Sciences, Azienda Ospedaliera Universitaria Integrata and University of Verona (Italy), 3. Department of Urology, University of Rome La Cattolica, Rome (Italy), 4. Referent for the Prostate Group of AIRO - Italian Association for Radiation Oncology, 5. Medical Oncology, Ospedale San Donato, Azienda USL8, Arezzo (Italy), 6. Department of Urology, St. Anna Hospital, Como, Italy (Italy), 7. Department of Radiation Oncology, AOU IRCCS San Martino - IST National Cancer Research Institute and University, Genoa (Italy), 8. Ospedale S. Giuseppe, Milan (Italy), 9. CNR, Neuroscience Institute, Aging Branch, Padua (Italy), 10. Radiation Oncology Unit, University of Brescia and Spedali Civili Hospital, Brescia (Italy), 11. Department of Radiation Oncology, University “La Sapienza”, Rome (Italy), 12. Department of Urology, University Federico II, Naples (Italy), 13. Section of Pathological Anatomy, Polytechnic University of the Marche Region (Italy), 14. Department of Urology, Campus Bio-Medico University of Rome (Italy), 15. Department of Nephrourology, Malzoni Center, Avellino (Italy), 16. Department of Urology, Abano Terme General Hospital, Padua (Italy), 17. Department of Oncology, Radiation Oncology, University of Torino (Italy), 18. Sant'Andrea Hospital, Sapienza University of Rome (Italy), 19. Medical Oncology Unit, Istituto Oncologico Veneto IOV – IRCCS, Padua (Italy), 20. Urology Clinic, University of Padua (Italy)
Quality of Life (QoL), Pre-Clinical testing, Male, Questionnaire